Skip to main content

Advertisement

Log in

BAG-1 inhibits p53-induced but not apoptin-induced apoptosis

  • Published:
Apoptosis Aims and scope Submit manuscript

Abstract

BAG-1 has been identified as a Bcl-2-binding protein that inhibits apoptosis, either alone or in co-operation with Bcl-2. Here we show that BAG-1 inhibits p53- induced apoptosis in the human tumour cell line Saos-2. In contrast, BAG-1 was unable to inhibit the p53-independent pathway induced by apoptin, an apoptosis-inducing protein derived from chicken anaemia virus. Whereas BAG-1 seemed to co-operate with Bcl-2 to repress p53-induced apoptosis, co-expression of these proteins had no inhibitory effect on apoptin-induced apoptosis. Moreover, Bcl-2, and to some extent also BAG-1, paradoxically enhanced the apoptotic activity of apoptin. These results demonstrate that p53 and apoptin induce apoptosis through independent pathways, which are differentially regulated by BAG-1 and Bcl-2.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Fraser A, Evan G. A license to kill. Cell 1996; 85: 781–784.

    Google Scholar 

  2. White E. Life, death, and the pursuit of apoptosis. Genes Dev 1996; 10: 1–15.

    Google Scholar 

  3. Korsmeyer SJ. Regulators of cell death. Trends in Gen 1995; 11: 101–105.

    Google Scholar 

  4. Wyllie AH. The genetic regulation of apoptosis. Curr Opin Genet Dev 1995; 5: 97–104.

    Google Scholar 

  5. Hengartner MO. Programmed cell death in invertebrates. Curr Opin Genet Dev 1996; 6: 34–38.

    Google Scholar 

  6. Canman CE, Kastan MB. Induction of apoptosis by tumor suppressor genes and oncogenes. Semin Canc Biol 1995; 6: 17–25.

    Google Scholar 

  7. Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994; 124: 1–6.

    Google Scholar 

  8. Craig RW. The bcl-2 gene family. Semin Cancer Biol 1995; 6: 35–43.

    Google Scholar 

  9. Boise LH, Gottschalk AR, Quintans J, Thompson CB. Bcl-2 and Bcl-2-related proteins in apoptosis regulation. Curr Top Microbiol Immunol 1995; 200: 107–121.

    Google Scholar 

  10. Cory S. Regulation of lymphocyte survival by the bcl-2 gene family. Annu Rev Immunol 1995; 13: 513–543.

    Google Scholar 

  11. Takayama S, Sato T, Krajewski S, et al. Cloning and functional analysis of BAG-1: a novel Bcl-2-binding protein with anti-cell death activity. Cell 1995; 80: 279–284.

    Google Scholar 

  12. Wang H-G, Takayama S, Rapp UR, Reed JC. Bcl-2 interacting protein, BAG-1, binds to and activates the kinase Raf-1. Proc Natl Acad Sci USA 1996; 93: 7063–7068.

    Google Scholar 

  13. Kastan MB, Canman CE, Leonard CJ. p53, cell cycle control and apoptosis: implications for cancer. Cancer Metastasis Rev 1995; 14: 3–15.

    Google Scholar 

  14. Vogelstein B, Kinzler KW. p53 function and dysfunction. Cell 1992; 70: 523–526.

    Google Scholar 

  15. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995; 80: 293–299.

    Google Scholar 

  16. Miyashita T, Krajewski S, Krajewska M, et al. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 1994; 9: 1799–1805.

    Google Scholar 

  17. Noteborn MHM, Todd D, Verschueren CAJ, et al. A single chicken anemia virus protein induces apoptosis. J Virol 1994; 68: 346–351.

    Google Scholar 

  18. Zhuang S-M, Landegent JE, Verschueren CAJ, et al. Apoptin, a protein encoded by chicken anemia virus, induces cell death in various human hematologic malignant cells in vitro. Leukemia 1995; 9: S118–S120.

    Google Scholar 

  19. Zhuang S-M, Shvarts A, Van Ormondt H, Jochemsen AG, Van der Eb AJ, Noteborn MHM. Apoptin, a protein derived from chicken anemia virus, induces p53-independent apoptosis in human osteosarcoma cells. Cancer Res 1995; 55: 486–489.

    Google Scholar 

  20. Zhuang S-M, Shvarts A, Jochemsen AG, Van Oorschot AAAM, Van der Eb AJ, Noteborn MHM. Differential sensitivity to Ad5 E1B-21kD and Bcl-2 proteins of apoptin-induced versus p53-induced apoptosis. Carcinogenesis 1995; 16: 2939–2944.

    Google Scholar 

  21. Baker SJ, Markowitz S, Fearon ER, Willson JKV, Vogelstein B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 1990; 249: 912–915.

    Google Scholar 

  22. Menke AL, Shvarts A, Riteco N, Van Ham RCA, Van der Eb AJ, Jochemsen AG. Wilms' tumor 1-KTS isoforms induce p53 independent apoptosis that can be partially rescued by expression of the epidermal growth factor receptor or the insulin receptor. Cancer Res 1997; 57: 1353–1363.

    Google Scholar 

  23. Van der Eb AJ, Graham FL. Assay of transforming activity of tumor virus DNA. Meth Enzymol 1980; 65: 826–839.

    Google Scholar 

  24. Van den Heuvel SJL, Van Laar T, Kast WM, Melief CJ, Zantema A, Van der Eb AJ. Association between the cellular p53 and the adenovirus 5 E1B-55kD proteins reduces the oncogenicity of Ad-transformed cells. EMBO J 1990; 9: 2621–2629.

    Google Scholar 

  25. Noteborn MHM, De Boer GF, Van Roozelaar DJ, et al. Characterization of cloned chicken anemia virus DNA that contains all elements for the infectious replication cycle. J Virol 1991; 65: 3131–3139.

    Google Scholar 

  26. Gurney EG, Harrison RO, Fenno J. Monoclonal antibodies against simian virus 40 T antigens: evidence for distinct subclasses of large T antigen and for similarities among nonviral T antigens. J Virol 1980; 34: 752–763.

    Google Scholar 

  27. Danen-van Oorschot AAAM, Fischer DF, Grimbergen J, et al. Apoptin induces apoptosis in human transformed and malignant cells but not in normal cells. Proc Natl Acad Sci USA 1997; 94: 5843–5847.

    Google Scholar 

  28. Krajewski S, Tanaka S, Takayama S, Schibler M, Fenton W, Reed JC. Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res 1993; 53: 4701–4714.

    Google Scholar 

  29. Van den Heuvel SJL, Van Laar T, The I, Van der Eb AJ. Large E1B proteins of adenovirus types 5 and 12 have different effects on p53 and distinct roles in cell transformation. J Virol 1993; 67: 5226–5234.

    Google Scholar 

  30. Sabbatini P, Jiayuh L, Levine AJ, White E. Essential role for p53-mediated transcription in E1A-induced apoptosis. Genes & Dev 1995; 9: 2184–2192.

    Google Scholar 

  31. Strasser A, Harris AW, Huang DCS, Krammer PH, Cory S. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J 1995; 14: 6136–6147.

    Google Scholar 

  32. Tsujimoto Y, Cossman J, Jaffe B, Croce CM. Involvement of the bcl-2 gene in human follicular lymphoma. Science 1985; 228: 1440–1443.

    Google Scholar 

  33. Campos L, Rouault JP, Sabido O, et al. High expression of the bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood 1993; 18: 3091–3096.

    Google Scholar 

  34. Reed JC, Meister L, Tanaka S, et al. Differential expression of bcl-2 proto oncogene in neuroblastoma and other human tumor cell lines of neural origin. Cancer Res 1991; 51: 6529–6538.

    Google Scholar 

  35. McDonnell T, Troncoso P, Brisbay S, et al. Expression of the proto oncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res 1992; 52: 6940–6944.

    Google Scholar 

  36. Lotem J, Sachs L. Control of apoptosis in hematopoiesis and leukemia by cytokines, tumor suppressor and oncogenes. Leukemia 1996; 10: 925–931.

    Google Scholar 

  37. Reed JC. Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance. Curr Opin Oncol 1995; 7: 541–546.

    Google Scholar 

  38. Hooper ML. The role of the p53 and Rb-1 genes in cancer, development and apoptosis. J Cell Sci Suppl 1994; 18: 13–17.

    Google Scholar 

  39. Lowe SW, Bodis S, McClatchey A, et al. p53 status and the efficacy of cancer therapy in vivo. Science 1994; 266: 807–810.

    Google Scholar 

  40. Smith ML, Fornace Jr AJ. Genomic instability and the role of p53 mutations in cancer cells. Cur Op Onc 1995; 7: 69–75.

    Google Scholar 

  41. Hockenberry DM. bcl-2 in cancer, development and apoptosis. J Cell Sci Suppl 1994; 18: 51–55.

    Google Scholar 

  42. Wyllie AH. Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview. Canc Metast Rev 1992; 11: 95–103.

    Google Scholar 

  43. Sachs L, Lotem J. Control of programmed cell death in normal and leukemic cells: new implications for therapy. Blood 1993; 82: 15–21.

    Google Scholar 

  44. Dive C, Wyllie AH. Apoptosis and cancer chemotherapy. In: Hickman JA, Tritton TT, eds. Frontiers in Pharmacology: Cancer Chemotherapy. Oxford, UK: Blackwell Scientific, 1993: 21–56.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Danen-van Oorschot, A.A.A.M., den Hollander, A.I., Takayama, S. et al. BAG-1 inhibits p53-induced but not apoptin-induced apoptosis. Apoptosis 2, 395–402 (1997). https://doi.org/10.1023/A:1026409808732

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1026409808732

Navigation